56 Publikationen
-
2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2988661Braun J, Märker-Hermann E, Rudwaleit M, Sieper J (2024)PUB | DOI | WoS | PubMed | Europe PMC
HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis.
Annals of the Rheumatic Diseases. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2988304Seifert RM, Rauch M, Klingebiel R, Boese L-M, Greeve I, Rudwaleit M, Schäbitz W-R (2023)PUB | PDF | DOI
Case report: Cerebral amyloid angiopathy-related inflammation in a patient with granulomatosis with polyangiitis.
Frontiers in Neurology 14. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2985913Rudwaleit M, Morup M, Humphries B, Zannat N-E, Willems D, Taieb V, Boonen A (2023)PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis.
RMD Open 9(4): e003468. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984077Löffler C, Rudwaleit M, Lakomek H-J, Stammann C, Hellmich B (2023)PUB | DOI | WoS | PubMed | Europe PMC
Patient-reported-Outcomes bei Vaskulitispatienten in Deutschland – Daten aus dem KOBRA-Qualitätsprojekt.
Zeitschrift für Rheumatologie. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987167Rudwaleit M, Brown M, Van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, De Peyrecave N, Vaux T, White K, Deodhar A, Van der Horst-Bruinsma I (2023)PUB | DOI | WoS
LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: POOLED RESULTS FROM PHASE 2B/3 TRIALS.
Annals of the Rheumatic Diseases 82(Suppl. 1): 614-615. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987166Rudwaleit M, Van den Bosch F, Marzo-Ortega H, Navarro-Compán V, Tham R, Kumke T, Bauer L, Kim M, Gensler LS (2023)PUB | DOI | WoS
AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT BETWEEN OBJECTIVE INFLAMMATORY RESPONSE AND CLINICAL RESPONSE FOLLOWING CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS.
Annals of the Rheumatic Diseases 82(Suppl. 1): 624-625. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987165Baraliakos X, Machado P, Bauer L, Hoepken B, Kim M, Kumke T, Tham R, Rudwaleit M (2023)PUB | DOI | WoS
COMPARISON OF ESTABLISHED AND NEW, PRELIMINARY PROPOSED ASAS CUT-OFFS FOR INFLAMMATORY MRI LESIONS IN THE SACROILIAC JOINTS OF AXIAL SPONDYLOARTHRITIS PATIENTS AND IMPLICATIONS FOR RECRUITMENT IN CLINICAL STUDIES.
Annals of the Rheumatic Diseases 82(Suppl. 1): 621-622. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987161Torgutalp M, Peng X, Proft F, Rodriguez VR, Rademacher J, Protopopov M, Haibel H, Rudwaleit M, Sieper J, Poddubnyy D (2023)PUB | DOI | WoS
FACTORS ASSOCIATED WITH ACHIEVING REMISSION IN PATIENTS WITH EARLY PERIPHERAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT (GESPIC).
Annals of the Rheumatic Diseases 82(Suppl. 1): 37-38. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987156Schmidt JF, Kiltz U, Stammann C, Schubert-Haack J, Strunk J, Lakomek HJ, Braun J, Rudwaleit M (2023)PUB | DOI | WoS
QUALITY STANDARDS FOR PATIENTS WITH AXSPA - STATUS QUO OF DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF AXSPA PATIENTS IN GERMANY.
Annals of the Rheumatic Diseases 82(Suppl. 1): 1713. -
-
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987168Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, De Peyrecave N, Vaux T, Marzo-Ortega H, Navarro-Compán V (2023)PUB | DOI | WoS
ACHIEVEMENT OF LOW DISEASE ACTIVITY OVER 52 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS ON BIMEKIZUMAB TREATMENT: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2.
Annals of the Rheumatic Diseases 82(Suppl. 1): 875-876. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987172Albrecht K, Thiele K, Aringer M, Callhoff J, Karberg K, Krueger K, Lakomek J, Lorenz HM, Rudwaleit M, Schmale-Grede R, Schneider M, Spaethling-Mestekemper S, Specker C, Zinke S, Braun J, Kiltz U (2023)PUB | DOI | WoS
IMPLEMENTATION OF QUALITY STANDARDS FOR HEALTH CARE OF PATIENTS WITH RHEUMATOID ARTHRITIS: FIRST RESULTS FROM THE NATIONAL DATABASE OF THE GERMAN COLLABORATIVE ARTHRITIS CENTRES.
Annals of the Rheumatic Diseases 82(Suppl. 1): 868-869. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987170Magrey M, Deodhar A, Mease PJ, Navarro-Compán V, Ramiro S, Rudwaleit M, De la Loge C, Fleurinck C, Taieb V, Morup M, Oortgiesen M, Kay J (2023)PUB | DOI | WoS
ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB.
Annals of the Rheumatic Diseases 82(Suppl. 1): 1721. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987174Navarro-Compán V, Benavent D, Capelusnik D, Van der Heijde D, Landewé RBM, Poddubnyy D, Van Tubergen A, Baraliakos X, Van den Bosch F, Van Gaalen FA, Gensler LS, López-Medina C, Marzo-Ortega H, Moltó A, Perez Alamino R, Rudwaleit M, Van de Sande MGH, Sengupta R, Weber U, Ramiro S (2023)PUB | DOI | WoS
ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS.
Annals of the Rheumatic Diseases 82(Suppl. 1): 35-36. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2986690van Gaalen FA, Rudwaleit M (2023)PUB | DOI | WoS | PubMed | Europe PMC
Challenges in the diagnosis of axial spondyloarthritis.
Best Practice & Research Clinical Rheumatology 37(3): 101871. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2985592Braun J, Rudwaleit M, Sieper J (2023)PUB | DOI | WoS | PubMed | Europe PMC
Zur Rolle von HLA-B27 in der Pathogenese und Diagnostik der axialen Spondyloarthritis. 50 Jahre nach Entdeckung der starken genetischen Assoziation.
Zeitschrift fur Rheumatologie. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2983818Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, de Peyrecave N, Vaux T, Giger S, Marzo OH, Compan N (2023)PUB | DOI | WoS
Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2.
In: Abstracts of the Annual meeting of theSwiss Society of Rheumatology. Swiss Medical Weekly, 153. Basel: EMH Schweizerischer Ärzteverlag: 23S. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2984578Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, de Peyrecave N, Vaux T, Sarno A, Marzo-Ortega H, Navarro-Compan V (2023)PUB | DOI | WoS
Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the Phase 3 studies BE MOBILE 1 and BE MOBILE 2.
In: Abstract Supplement - 39th Scandinavian Congress of Rheumatology. Scandinavian Journal of Rheumatology , 52. Abingdon: Taylor & Francis : 73-74. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2982993Rudwaleit M, Machado PM, Taieb V, de Peyrecave N, Hoepken B, Gensler LS (2023)PUB | DOI | PubMed | Europe PMC
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis.
Therapeutic Advances in Musculoskeletal Disease 15. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982790Zochling J, Robinson PC, Maksymowych WP, Gensler LS, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2023)PUB | DOI | WoS
Long-term clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis stratified by baseline MRI and c-reactive protein status.
Internal Medicine Journal 53(Suppl. 1): 25. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982783Rudwaleit M, Morup M, Humphries B, Zannat NE, Willems D, Taieb V, Boonen A (2023)PUB | DOI | WoS
Systematic Literature Review and Meta-Analysis of Work Productivity in Patients with Axial Spondyloarthritis Treated with Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs.
Value in Health 26(6 Suppl.): S397. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982796Bird P, Mease PJ, Deodhar A, Dougados M, Dubreuil M, Magrey M, Marzo-Ortega H, Rudwaleit M, de la Loge C, Ellis A, Fleurinck C, Oortgiesen M, Taieb V, Gensler LS (2023)PUB | WoS
Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies.
Internal Medicine Journal 53(S2): 24-25. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968910Braun J, Rudwaleit M, Sieper J, Specker C (2023)PUB | DOI | WoS | PubMed | Europe PMC
Nachruf der Deutschen Gesellschaft für Rheumatologie (DGRh) auf den Träger der Kussmaul-Medaille der DGRh Prof. Dr. Ernst Feldtkeller.
Zeitschrift für Rheumatologie. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968373Röchter M-H, Rudwaleit M (2023)PUB | DOI | WoS | PubMed | Europe PMC
Phänomen der letzten Wiese.
Zeitschrift fur Rheumatologie. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968388van der Heijde D, Deodhar A, Baraliakos X, Brown MA, Dobashi H, Dougados M, Elewaut D, Ellis AM, Fleurinck C, Gaffney K, Gensler LS, Haroon N, Magrey M, Maksymowych WP, Marten A, Massow U, Oortgiesen M, Poddubnyy D, Rudwaleit M, Shepherd-Smith J, Tomita T, Van den Bosch F, Vaux T, Xu H (2023)PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials.
Annals of the Rheumatic Diseases. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2969537Magrey M, Deodhar A, Mease PJ, Navarro-Compan V, Ramiro S, Rudwaleit M, de la Loge C, Fleurinck C, Taieb V, Morup MF, Oortgiesen M, Kay J (2022)PUB | DOI | WoS
Association of Clinical Response Criteria and Disease Activity Levels With Physical Function and HRQoL in Patients With Active Axial Spondyloarthritis: 16-Week Results From Two Phase 3 Randomised, Placebo-Controlled Studies.
In: ISPOR Europe 2022 Abstracts. Value in Health, 25. New York: Elsevier : S427-S428. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968210Torgutalp M, Rios-Rodriguez V, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)PUB | DOI | WoS
Treatment with Non-steroidal Anti-inflammatory Drugs Is Associated with Retardation of Radiographic Spinal Progression in Patients with Axial Spondyloarthritis: 10-year Results from the GErman SPondyloarthritis Inception Cohort.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 2946-2948. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968211Baraliakos X, Machado P, Bauer L, Hoepken B, Kim M, Kumke T, Tham R, Rudwaleit M (2022)PUB | DOI | WoS
Comparison of Established and New, Preliminarily Proposed ASAS Cut-Offs for Inflammatory MRI Lesions in the Sacroiliac Joints of Axial Spondyloarthritis Patients and Implications for Recruitment in Clinical Studies.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 1997-2000. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968213Brandt-Juergens J, Rudwaleit M, Behrens F, Ritchlin C, Peterlik D, Quebe-Fehling E, Calheiros R, Deodhar A (2022)PUB | DOI | WoS
Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 2074-2076. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968219Deodhar A, van der Heijde D, Gensler L, Xu H, Gaffney K, Dobashi H, Maksymowych WP, Rudwaleit M, Magrey M, Elewaut D, Oortgiesen M, Fleurinck C, de Peyrecave N, Ellis A, Vaux T, Shepherd-Smith J, Baraliakos X (2022)PUB | DOI | WoS
Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients with Active Non-Radiographic Axial Spondyloarthritis: 24-Week Efficacy & Safety from a Phase 3, Multicenter, Randomized, Placebo Controlled Study.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 1101-1105. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968220Diekhoff T, Eshed I, Giraudo C, Haibel H, Hermann K-G, de Hooge M, Jans L, Jurik A, Lambert RG, Machado P, Maksymowych WP, Mallinson M, Marzo-Ortega H, Navarro-Compan V, Pedersen S, Ostergaard M, Reijnierse M, Rudwaleit M, Sommerfleck FA, Weber U, Baraliakos X, Poddubnyy D (2022)PUB | DOI | WoS
ASAS Recommendations for Requesting and Reporting Imaging in Patients with Suspected Axial Spondyloarthritis.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Reumatology (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 788-790. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968222Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewe R, Van den Bosch F, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen F, Geher P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, Lopez-Medina C, Machado P, Marzo-Ortega H, Molto A, Navarro-Compan V, Nissen M, Pimentel-Santos F, Poddubnyy D, Proft F, Rudwaleit M, Telkman M, Zhao S, Ziade N, van der Heijde D (2022)PUB | DOI | WoS | PubMed | Europe PMC
ASAS-EULAR Recommendations for the Management of Axial Spondyloarthritis: 2022 Update.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022 ,November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 1094-1097. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968218Mease PJ, Deodhar A, Dougados M, Dubreuil M, Magrey M, Marzo-Ortega H, Rudwaleit M, De la Loge C, Ellis A, Fleurinck C, Oortgiesen M, Taieb V, Gensler L (2022)PUB | DOI | WoS
Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatolgy (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 810-813. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968217Maksymowych WP, Ostergaard M, Baraliakos X, Machado P, Pedersen SJ, Weber U, Eshed I, de Hooge M, Sieper J, Poddubnyy D, Rudwaleit M, van der Heijde D, Landewe R, Lambert RG (2022)PUB | DOI | WoS
MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 4490-4492. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968216Magrey M, Deodhar A, Mease PJ, Navarro-Compan V, Ramiro S, Rudwaleit M, De la Loge C, Fleurinck C, Taieb V, Morup MF, Oortgiesen M, Kay J (2022)PUB | DOI | WoS
Achieving Increasingly Stringent Clinical Response Criteria & Lower Levels of Disease Activity Is Associated with Greater Improvements in Physical Function & HRQoL in Patients with Active Axial Spondyloarthritis: 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 814-816. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968215Rudwaleit M, Van den Bosch F, Marzo-Ortega H, Navarro-Compan V, Tham R, Kumke T, Bauer L, Kim M, Gensler L (2022)PUB | DOI | WoS
An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 1097-1100. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968214Robinson PC, Maksymowych WP, Gensler L, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2022)PUB | DOI | WoS
Long-Term Clinical Outcomes of Certolizumab Pegol Treatment in Patients with Active Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status.
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74. Hoboken: Wiley: 808-810. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966738Navarro-Compan V, Rudwaleit M, De Peyrecave N, Fleurinck C, Oortgiesen M, Taieb V, Baraliakos X (2022)PUB | DOI | WoS
MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION.
Annals of the Rheumatic Diseases 81(Suppl. 1): 771-772. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966741Torgutalp M, Rodriguez VR, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)PUB | DOI | WoS
TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IS ASSOCIATED WITH RETARDATION OF RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT.
In: Annals of the Rheumatic Diseases. 81. London: Bmj Publishing Group: 14-15. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966746Robinson P, Maksymowych WP, Gensler LS, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2022)PUB | DOI | WoS
LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS.
In: Annals of the Rheumatic Diseases. 81. London: Bmj Publishing Group: 774-775. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966748Deodhar A, Van der Heijde D, Gensler LS, Xu H, Gaffney K, Dobashi H, Maksymowych WP, Rudwaleit M, Magrey M, Elewaut D, Oortgiesen M, Fleurinck C, Ellis A, Vaux T, Smith J, Baraliakos X (2022)PUB | DOI | WoS
BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY.
In: Annals of the Rheumatic Diseases. 81. London: Bmj Publishing Group: 772-773. -
2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2965259Torgutalp M, Rodriguez VR, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)PUB | DOI | WoS | PubMed | Europe PMC
Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort.
Arthritis & Rheumatology . -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2963951Torgutalp M, Rios Rodriguez V, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)PUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis.
Annals of the rheumatic diseases 81(9): 1252-1259. -
2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2964357Robinson PC, Maksymowych WP, Gensler LS, Hall S, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, de Peyrecave N, Deodhar A (2022)PUB | DOI | WoS | PubMed | Europe PMC
Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study.
ACR Open Rheumatology. -
2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2963700Baraliakos X, Ostergaard M, Lambert RG, Eshed I, Machado PM, Pedersen SJ, Weber U, de Hooge M, Sieper J, Poddubnyy D, Rudwaleit M, van der Heijde D, Landewe RB, Maksymowych W (2022)PUB | DOI | WoS | PubMed | Europe PMC
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group.
Annals of the Rheumatic Diseases. -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2962214van der Heijde D, Gensler LS, Maksymowych WP, Landewe R, Rudwaleit M, Bauer L, Kumke T, Kim M, Auteri SE, Hoepken B, Deodhar A (2022)PUB | DOI | WoS | PubMed | Europe PMC
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study.
RMD Open 8(1): e002138. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961894Baraliakos X, Rodriguez VR, Torgutalp M, Dilbaryan A, Haibel H, Verba M, Sieper J, Braun J, Rudwaleit M, Poddubnyy D (2021)PUB | DOI | WoS
Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time?
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73. Hoboken: Wiley: 319-321. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961900Maksymowych W, Lambert R, Baraliakos X, Pedersen S, Eshed I, Weber U, Machado P, De Hooge M, Sieper J, Wichuk S, Poddubnyy D, Rudwaleit M, Landewe R, van der Heijde D, Ostergaard M (2021)PUB | DOI | WoS
Data-driven Definitions Based on Inflammatory Lesions for a Positive MRI of the Spine Consistent with Axial Spondyloarthritis.
In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73. Hoboken: Wiley: 1878-1880. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961899Maksymowych W, Weber U, Baraliakos X, Machado P, Pedersen S, Sieper J, Wichuk S, Poddubnyy D, Rudwaleit M, van der Heijde D, Landewe R, Paschke J, Ostergaard M, Lambert R (2021)PUB | DOI | WoS
Scoring MRI Structural Lesions in Sacroiliac Joints of Patients with Axial Spondyloarthritis: How Many Slices Are Optimal?
In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73. Hoboken: Wiley: 1876-1878. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961897van der Heijde D, Gensler L, Maksymowych W, Landewe R, Rudwaleit M, Bauer L, Hoepken B, Kumke T, Kim M, Deodhar A (2021)PUB | DOI | WoS
Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Active Non-Radiographic Axial Spondyloarthritis: 3-Year Results from a Phase 3 Multicenter Study.
In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73. Hoboken: Wiley: 1896-1899. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961896Magrey M, Ramiro SA, Pinheiro MM, Gao T, Ganz F, Song I-H, Biljan A, Haroon N, Rudwaleit M (2021)PUB | DOI | WoS
Predictors of 1-Year Treatment Response Among Upadacitinib-Treated Patients with Ankylosing Spondylitis: A Post Hoc Analysis.
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73. Hoboken: Wiley: 1931-1933. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961895Rudwaleit M, Machado P, Gensler L, Taieb V, de Peyrecave N, Hoepken B, van der Heijde D (2021)PUB | DOI | WoS
Achievement of Stringent Thresholds of Disease Control Is Associated with Reduced Burden on Work and Household Productivity in Patients with Axial Spondyloarthritis.
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73. Hoboken: Wiley: 734-738. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961892Torgutalp M, Rodriguez VR, Verba M, Protopopov M, Proft F, Rademacher J, Haibel H, Rudwaleit M, Sieper J, Poddubnyy D (2021)PUB | DOI | WoS
Tumor Necrosis Factor Inhibitors Show a Delayed Effect on Radiographic Sacroiliitis Progression in Patients with Early Axial Spondyloarthritis: 10-Year Results from the German Spondyloarthritis Inception Cohort.
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73. Hoboken: Wiley: 931-933. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961881Kristensen LE, McGonagle D, Rudwaleit M, Kameda H, Holzkaemper T, El Baou C, Smolen J (2021)PUB | DOI | WoS
Association of the improvement of Synovitis and Enthesitis with quality of life/patient reported outcomes in patients with PsA treated with Ixekizumab.
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73. Hoboken: Wiley: 3722-3724. -
2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2959486Maksymowych WP, Kumke T, Auteri SE, Hoepken B, Bauer L, Rudwaleit M (2021)PUB | DOI | WoS | PubMed | Europe PMC
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol.
Arthritis Research and Therapy 23(1): 274. -
2021 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2958359Kiltz U, Buschhorn-Milberger V, Albrecht K, Lakomek H-J, Lorenz H-M, Rudwaleit M, Schneider M, Schulze-Koops H, Aringer M, Hasenbring MI, Herzer P, von Hinuber U, Kruger K, Lauterbach A, Manger B, Oltman R, Schuch F, Schmale-Grede R, Spathling-Mestekemper S, Zinke S, Braun J (2021)PUB | DOI | WoS | PubMed | Europe PMC
Entwicklung von Qualitätsstandards für die Versorgung von Patient*innen mit rheumatoider Arthritis zur Anwendung in Deutschland.
Zeitschrift fur Rheumatologie.